S-adenosylmethionine in the treatment of depression

S A Vahora; P Malek-Ahmadi

doi:10.1016/s0149-7634(88)80005-8

S-adenosylmethionine in the treatment of depression

Neurosci Biobehav Rev. 1988 Summer;12(2):139-41. doi: 10.1016/s0149-7634(88)80005-8.

Authors

S A Vahora¹, P Malek-Ahmadi

Affiliation

¹ Texas Tech University, School of Medicine, Department of Psychiatry, Lubbock 79430.

PMID: 3050630
DOI: 10.1016/s0149-7634(88)80005-8

Abstract

The antidepressant property of S-adenosylmethionine (SAMe) has been supported by several uncontrolled and controlled studies. Compared to standard antidepressant agents, SAMe has fewer side-effects and shorter lag period. Future studies to delineate SAMe-responsive depression are warranted.

Publication types

Clinical Trial
Review

MeSH terms

Clinical Trials as Topic
Depressive Disorder / drug therapy*
Humans
S-Adenosylmethionine / therapeutic use*

Substances

S-Adenosylmethionine